[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Keep calm and carry on", "description": "", "link": "https://www.youtube.com/watch?v=ayQvcu20j7A", "date_published": "2020-12-10 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Thursday 10 December Pandemic Update", "description": "UK\n\nTracker app (King\u2019s)\n\nhttps://covid.joinzoe.com/data#levels-over-time\n\nUK, cases have halved since October peak\n\nUK Infection Survey figures based on swab tests data from up to five days ago\n\nNew cases of in the UK are continuing to fall\n\nScotland and Wales have plateaued. \n\nCases, + 20,497 day\n\nLast week, cases, + 29,311 \n\nSix weeks ago, cases, + 42,000\n\nUK R value is 0.8\n\nEngland, 0.8\n\nWales, 1.0\n\nScotland, 1.0 (40,000 infections)\n\nEngland, daily new cases are continuing to decrease in every region\n\nDaily new cases continue to fall in over 60s group\n\nOfficial data\n\nhttps://coronavirus.data.gov.uk/details/cases\n\n\nCDC trends (Thursday, 10th December)\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nThanksgiving surge, peak next week\n\nCases, + 217,046 + 211,027 (220,000) = 15,142,845\n\nIncrease in cases in last 7 days = 10.4%\n\nOfficial US hospitalizations\n\nhttps://gis.cdc.gov/grasp/COVIDNet/COVID19_3.html\n \nhttps://covidtracking.com\n\nCalifornia, high hospitalization rate\n\nCurrent hospitalizations, 106,688 (20,992)\n\nVentilated, 7,624\n\nDeaths, + 3,140 = 280,454\n\nState department, 200 guests\n\nApproves Pfizer vaccine\n\nUK\n\nBahrain\n\nCanada\n\nSaudi Arabia\n\nNBC\n\nUK starts mass inoculations\n\nCaution shot\n\nA new warning of side effects\n\nAnother issue for US regulators to consider\n\nIt\u2019s a setback for PM Boris Johnson\n\nCanada undaunted\n\nUS rollout\n\nFedEx, East\n\nUps, West\n\nPopulation allocation\n\nEvery package chipped\n\n2020, 40 million doses\n\nEnd of January, 50 million doses\n\nMr. Biden, 100 million shots in first 100 days\n\nFDA Oxford vaccine\n\nFull data middle of next year with a long follow up\n\n300 million on order\n\nNew York City Department of Health, 1954\n\nWalter Winchell, inactivated polio virus by Jonas Salk, may be a killer\n\nElvis publicly received the vaccine, 1956\n\nNext year, 900 thousand New Yorkers vaccinated\n\nNew cases started to drop\n\nWorld leaders\n\nNetanyahu, (71) agreed public vaccination\n\nMohammed bin Rashid al-Maktoum, Dubai (71) last month, photographed receiving China vaccine\n\nVladimir Putin, daughter\n\nJoe Biden, Bill Clinton, George W. Bush, Barack Obama, all pledged\n\nPresident Trump\n\nBoris Johnson \n\nSweden\n\nIntensive care beds, Stockholm, 99% full\n\nFive to seven beds available out of 160 on Wednesday\n\nStockholm, hospitalised, 814, up from 748 last Friday\n\nSweden has never imposed a nationwide lockdown\n\nSouth Africa\n\nSecond wave\n\nSurge of infections, aged between 15 and 19\n\nCape Town night club, university in Nelson Mandela Bay \n\nCrowded parties, end of school year, drinking\n\nZimbabwe and Kenya, also increases\n\nEurope\n\nGermany\n\nCases, + 23,679\n\nAngela Merkel asks for more acceptance of measures\n\nFrance\n\nCases, + 14,500\n\nPrime Minister Jean Castex, relaxation of lockdown measures today\nbut not as fast as planned\n\nCzech\n\nCases, + 5,848\n\nExtended state of emergency until 23 December\n\nSlovakia\n\nSchools and most shops to be closed for at least three weeks from 21 December", "link": "https://www.youtube.com/watch?v=WndHeosSVGk", "date_published": "2020-12-10 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "First peer-reviewed vaccine evidence", "description": "V Day, good start\n\nThree-and-a-half, 975 doses\n\nOver-80s and NHS and care home staff\n\n70 hospital hubs\n\n800,000 doses\n\nOne million from Belgium by next week\n\n2020, 5 million doses\n\nTwo adverse reactions\n\nAnaphylactoid \n\nBoth shortly after\n\nBoth fine\n\nBoth history of serious allergies and carry adrenalin pens \n\nSevere allergic patents not in trials\n\nProfessor Stephen Powis\n\nAs is common with new vaccines, the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely\n\nDr June Raine, (MHRA)\n\nOnly right to take this step now that we've had this experience\n\n\nFirst peer-reviewed vaccine evidence\n\nSafety and efficacy of the ChAdOx1 nCoV-19 vaccine\n(AZD1222) against SARS-CoV-2: an interim analysis of\nfour randomised controlled trials in Brazil, South Africa,\nand the UK\n\nhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext\n\nOxford University\n\nReplication-deficient chimpanzee adenoviral vector\n\nContaining the SARS-CoV-2 structural surface\nglycoprotein antigen (spike protein; nCoV-19) gene.\n\nEvaluated the safety and efficacy\n\nMethods\n\nFour ongoing blinded, randomised, controlled trials\n\nUK, Brazil, and South Africa\n\nParticipants aged 18 +\n\nRandomly assigned, 1:1\n\nVaccine or control (meningococcal group conjugate vaccine or saline)\n\nVaccine group\n\nTwo doses containing 5\u2008\u00d7\u20081010 viral particles (standard dose)\n\nA subset in the UK trial, half dose first (low dose) and a standard dose second\n\nInfections recorded more than 14 days after a second dose\n\nData cutoff Nov 4, 2020\n\nApril 23 to Nov 4, 2020\n\n23,848 participants were enrolled\n\n11,636 participants (7548 in the UK, 4088 in Brazil), interim primary efficacy analysis\n\nThere were 131 cases of symptomatic COVID-19 in\n\nLD/SD or SD/SD recipients combined\n\nVaccine group\n\nN = 5,807\n\n30 cases\n\nControl group\n\nN = 5,829\n\n101 cases\n\nResulting in overall vaccine efficacy of 70.4%\n\nSD/SD group\n\nVaccine group, 27 cases \n\nControl group, 71 cases\n\nVaccine efficacy was 62\u00b71%\n\nUK, 60\u00b73% efficacy\n\nBrazil, 64\u00b72% efficacy\n\nLD/SD goup\n\nVaccine group, 3 cases from 1,367\n\nControl group 30 cases from 1,374\n\nVaccine efficacy was 90%\n\nLD/HD group had less asymptomatic infections\n\nSix week gap may also help\n\nImplications for ongoing contagion\n\nFrom 21 days after the first dose\n\nTen cases hospitalised for COVID-19, two classified as severe, one death\n\nVaccine efficacy 100%\n\nSafety\n\n74,341 person-months of safety follow-up\n\n175 severe adverse events occurred in 168 participants\n\n84 events in vaccine group\n\n91 in the control group\n\nThree events were classified as possibly related to a vaccine\n\nOne in the vaccine group, one in the control group", "link": "https://www.youtube.com/watch?v=5fXn1PCU2E8", "date_published": "2020-12-09 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]